MENLO PARK, Calif., Aug. 4, 2023 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that PacBio’s Compensation Committee of the Board of Directors granted non-qualified stock options covering an aggregate of…